Reports to the Vaccine Adverse Event Reporting System (VAERS) after Hepatitis A and Hepatitis AB Vaccines in Pregnant women

Ítems similars

• Adverse events after Fluzone® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011–2013()
  per: Moro, Pedro L., et al.
  Publicat: (2013)
• Enhanced Surveillance of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccines in Pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011 - 2015
  per: Moro, Pedro L., et al.
  Publicat: (2016)
• Assessing the safety of 9-valent human papillomavirus vaccine administration among pregnant women: adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014–2017
  per: Landazabal, Claudia S., et al.
  Publicat: (2019)
• Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990–2016
  per: Moro, Pedro L., et al.
  Publicat: (2017)
• Safety of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Pregnancy: Review of Non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006 – 2013
  per: Moro, Pedro L., et al.
  Publicat: (2014)